Baker McKenzie advised Avanza on the deal, and Lindahl assisted Brock Milton Capital AB. On March 28, 2025, Brock Milton Capital AB (publ) began trading on...
Brock Milton Capital’s Initial Public Offering
Nanologica AB’s Rights Offering
Lindahl advised Nanologica on the offering. Nanologica finalized a rights issuance, which was resolved by the board of directors on 29 August 2024 and approved by...
Corline Biomedical’s SEK 7.5 Million Licence Agreement with Imperative Care
Lindahl acted as legal advisor to Corline Biomedical in connection with the license agreement with the California-based company Imperative Care. The agreement concerns license rights to...
Senzime AB’s SEK 91.9 Million Shares Offering
Lindahl advised Senzime AB on the deal. Senzime AB (publ) announced a rights issue which was resolved by the board of directors on 23 January 2023 and...
Broviken’s Acquisition of Corplus
Lindahl assisted the owners of Corplus AB and Corplus Syd AB. Broviken Gruppen, which owns and develops qualified service companies, became principal owner of Corplus. The transaction...
Nanologica AB’s Uplisting on Nasdaq Stockhol Main Market
Lindahl advised Nanologica AB on the deal. Nanologica AB announced the company’s list change from Spotlight Stock Market to Nasdaq Stockholm’s main market. Nanologica manufactures, develops, and...
Electra Gruppen’s Merger With Elon Group
Vinge advised Electra Gruppen on the deal, while Lindahl has represented Elon Group. Electra Gruppen AB, listed on Nasdaq Stockholm, and Elon Group Holding AB (publ) entered...
Bergendahl & Son AB’s Acquisition of Majority Stake in KitchenTime AB
Lindahl advised KitchenTime on the deal. Bergendahl & Son AB has entered into an investment agreement regarding KitchenTime AB, where Bergendahl becomes the owner of 53% of...